CYTOBIN TAB 60MCG DIN 01908308
Health Canada record
| Active ingredient(s) | LIOTHYRONINE SODIUM 60 MCG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Veterinary |
| ATC | |
| Original market date | 31-Dec-1991 |
| Current status date | 10-Sep-1996 |
| Source | Health Canada DPD |
Establishment licence of the holder
Smithkline Beecham Ltd T/A Smithkline Beecham Pharmaceuticals — licence , not currently licensed, last inspection rating C (2024-12-20).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing LIOTHYRONINE SODIUM
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00318655 | CYTOBIN TAB 120MCG | NORDEN LABORATORIES INC. | Tablet | LIOTHYRONINE SODIUM 120 MCG | Cancelled Post Market |
| 01908316 | CYTOBIN TAB 120MCG | SMITHKLINE BEECHAM ANIMAL HEALTH | Tablet | LIOTHYRONINE SODIUM 120 MCG | Cancelled Post Market |
| 00318647 | CYTOBIN TAB 60MCG | NORDEN LABORATORIES INC. | Tablet | LIOTHYRONINE SODIUM 60 MCG | Cancelled Post Market |
International API supply for LIOTHYRONINE SODIUM
2 valid EDQM Certificates of Suitability from 2 holders. 5 active FDA Drug Master Files.
Request a quote for CYTOBIN TAB 60MCG